BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9007141)

  • 1. Future directions in therapeutic approaches for small cell lung cancer.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):136-8. PubMed ID: 9007141
    [No Abstract]   [Full Text] [Related]  

  • 2. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 1: Lung Cancer. Puerto Rico, March 12-16, 1997.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-162; quiz S12-163-S12-173. PubMed ID: 9340788
    [No Abstract]   [Full Text] [Related]  

  • 3. Irinotecan: summary and future directions.
    Johnson DH
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):46-7. PubMed ID: 11221021
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.
    Vokes EE
    Front Radiat Ther Oncol; 1992; 26():64-71. PubMed ID: 1324877
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy for non-small-cell lung cancer--new horizons.
    Reed CE; Carlson LS; Schiff RD; Seymore CH; Thompson KA
    J S C Med Assoc; 1990 May; 86(5):270-4. PubMed ID: 2160565
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of inoperable patients with non-small-cell lung cancer.
    Feld R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():19-24. PubMed ID: 7602831
    [No Abstract]   [Full Text] [Related]  

  • 7. New antineoplastic agents in lung cancer 1988-1993.
    Grant SC; Kris MG
    Cancer Treat Res; 1995; 72():323-47. PubMed ID: 7702990
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic treatment of non-small-cell lung cancer.
    Lal R; Enting D; Kristeleit H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S375-7. PubMed ID: 21944021
    [No Abstract]   [Full Text] [Related]  

  • 9. Multimodality management of regionally advanced non-small-cell lung cancer.
    Belani CP
    Semin Oncol; 1993 Aug; 20(4):302-14. PubMed ID: 8393590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advances in lung cancer].
    Pautier P
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):956-9. PubMed ID: 1363892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of lung cancer].
    Tomita M
    Gan No Rinsho; 1989 Jan; Spec No():128-37. PubMed ID: 2536852
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidisciplinary management of lung cancer.
    Debevec L; Debeljak A
    J Thorac Oncol; 2007 Jun; 2(6):577. PubMed ID: 17545858
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few.
    Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L
    J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829
    [No Abstract]   [Full Text] [Related]  

  • 14. Unresectable stage III non-small-cell lung cancer: lessons and directions from clinical trials research.
    Green MR
    J Natl Cancer Inst; 1991 Mar; 83(6):382-3. PubMed ID: 1847976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
    Stinchcombe TE; Lee CB; Moore DT; Rivera MP; Halle J; Limentani S; Rosenman JG; Socinski MA
    J Thorac Oncol; 2008 Nov; 3(11):1279-85. PubMed ID: 18978563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer.
    Bogart JA; Govindan R
    Clin Lung Cancer; 2006 Jan; 7(4):285-7. PubMed ID: 16512986
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation-chemotherapy interactions in limited small cell lung cancer.
    Livingston RB
    Front Radiat Ther Oncol; 1992; 26():72-82. PubMed ID: 1324878
    [No Abstract]   [Full Text] [Related]  

  • 20. Cure- or care-oriented regimen for stage III non-small-cell lung cancer?
    Hotta K; Nagio T; Matsuo K; Kiura K
    J Clin Oncol; 2011 Apr; 29(11):e320. PubMed ID: 21402605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.